447 related articles for article (PubMed ID: 32532126)
1. Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition.
Wilson RB; Archid R; Reymond MA
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532126
[TBL] [Abstract][Full Text] [Related]
2. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
[TBL] [Abstract][Full Text] [Related]
3. Arctigenin alleviates TGF-β1-induced epithelial-mesenchymal transition and PAI-1 expression via AMPK/NF-κB pathway in peritoneal mesothelial cells.
Jin G; Su Y; Dong Q; Zhao X; Zhang L; Yan X
Biochem Biophys Res Commun; 2019 Dec; 520(2):413-419. PubMed ID: 31607474
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.
Loureiro J; Sandoval P; del Peso G; Gónzalez-Mateo G; Fernández-Millara V; Santamaria B; Bajo MA; Sánchez-Tomero JA; Guerra-Azcona G; Selgas R; López-Cabrera M; Aguilera AI
PLoS One; 2013; 8(4):e61165. PubMed ID: 23637793
[TBL] [Abstract][Full Text] [Related]
5. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
Lho Y; Do JY; Heo JY; Kim AY; Kim SW; Kang SH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947038
[TBL] [Abstract][Full Text] [Related]
6. Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses.
Namvar S; Woolf AS; Zeef LA; Wilm T; Wilm B; Herrick SE
J Pathol; 2018 Aug; 245(4):491-501. PubMed ID: 29774544
[TBL] [Abstract][Full Text] [Related]
7. MiR-200a negatively regulates TGF-β
Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
[TBL] [Abstract][Full Text] [Related]
8. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
[TBL] [Abstract][Full Text] [Related]
9. Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage.
Loureiro J; Aguilera A; Selgas R; Sandoval P; Albar-Vizcaíno P; Pérez-Lozano ML; Ruiz-Carpio V; Majano PL; Lamas S; Rodríguez-Pascual F; Borras-Cuesta F; Dotor J; López-Cabrera M
J Am Soc Nephrol; 2011 Sep; 22(9):1682-95. PubMed ID: 21742730
[TBL] [Abstract][Full Text] [Related]
10. Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosis.
Strippoli R; Sandoval P; Moreno-Vicente R; Rossi L; Battistelli C; Terri M; Pascual-Antón L; Loureiro M; Matteini F; Calvo E; Jiménez-Heffernan JA; Gómez MJ; Jiménez-Jiménez V; Sánchez-Cabo F; Vázquez J; Tripodi M; López-Cabrera M; Del Pozo MÁ
Cell Death Dis; 2020 Aug; 11(8):647. PubMed ID: 32811813
[TBL] [Abstract][Full Text] [Related]
11. Effects of dexamethasone on the TGF-β1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells.
Jang YH; Shin HS; Sun Choi H; Ryu ES; Jin Kim M; Ki Min S; Lee JH; Kook Lee H; Kim KH; Kang DH
Lab Invest; 2013 Feb; 93(2):194-206. PubMed ID: 23207448
[TBL] [Abstract][Full Text] [Related]
12. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
13. Network-based integrated analysis of omics data reveal novel players of TGF-β1-induced EMT in human peritoneal mesothelial cells.
Han SM; Ryu HM; Suh J; Lee KJ; Choi SY; Choi S; Kim YL; Huh JY; Ha H
Sci Rep; 2019 Feb; 9(1):1497. PubMed ID: 30728376
[TBL] [Abstract][Full Text] [Related]
14. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.
Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y
Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780
[TBL] [Abstract][Full Text] [Related]
15. Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axis.
Zhang Y; Feng W; Peng X; Zhu L; Wang Z; Shen H; Chen C; Xiao L; Li S; Zhao Y; Lin M; Huang Y; Long H; Liang J
Lab Invest; 2022 Dec; 102(12):1346-1354. PubMed ID: 36307537
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hyperglycolysis in mesothelial cells prevents peritoneal fibrosis.
Si M; Wang Q; Li Y; Lin H; Luo D; Zhao W; Dou X; Liu J; Zhang H; Huang Y; Lou T; Hu Z; Peng H
Sci Transl Med; 2019 Jun; 11(495):. PubMed ID: 31167927
[TBL] [Abstract][Full Text] [Related]
17. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
[TBL] [Abstract][Full Text] [Related]
18. [Role of transforming growth factor-β1 in epithelial-mesenchymal transition of mesothelial cells and its effect on peritoneal metastasis of gastric cancer].
Lyu Z; Kong B; Liu X; Li F; Wang H; Xu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Jan; 18(1):54-7. PubMed ID: 25656033
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis.
Wilson RB
Pleura Peritoneum; 2018 Mar; 3(1):20180103. PubMed ID: 30911653
[TBL] [Abstract][Full Text] [Related]
20. Paricalcitol attenuates TGF-β1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome.
Ko J; Kang HJ; Kim DA; Ryu ES; Yu M; Lee H; Lee HK; Ryu HM; Park SH; Kim YL; Kang DH
FASEB J; 2019 Feb; 33(2):3035-3050. PubMed ID: 30354670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
